✦ LIBER ✦

Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults

✍ Scribed by Scott Kitchener; Michael Nissen; Peter Nasveld; Remi Forrat; Sutee Yoksan; Jean Lang; Jean-François Saluzzo

Book ID: 116958462
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 80 KB
Volume: 24
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2005.09.029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, Viremia and Immunogenicity of Sa

Safety, Viremia and Immunogenicity of Sanofi Pasteur Tetravalent Dengue Vaccine in Adults Previously Exposed to Live, Attenuated Flaviviruses

✍ M. Qiao; D. Shaw; R. Forrat; A. Wartel-Tram; J. Lang 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Safety and immunogenicity of a tetravale

Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults

✍ Karen L. Kotloff; Ali Fattom; Lisa Basham; Abbas Hawwari; Scott Harkonen; Robert 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 704 KB

Evaluation of the Langat/dengue 4 chimer

Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers

✍ Peter F. Wright; Sharon Ankrah; Susan E. Henderson; Anna P. Durbin; Jim Speicher 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 588 KB

Safety and immunogenicity of RIX4414 liv

Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants

✍ T Vesikari; A Karvonen; T Korhonen; M Espo; E Lebacq; J Forster; F Zepp; A Delem 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Safety, dose, immunogenicity, and transm

Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh

✍ Kazi Mizanur Rahman; Shams El Arifeen; K. Zaman; Mahbubur Rahman; Rubhana Raqib; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Recombinant-yeast-derived hepatitis b va

Recombinant-yeast-derived hepatitis b vaccine in healthy adults: Safety and two-year immunogenicity of early investigative lots of vaccine

✍ Lynn Butterly; Eloise Watkins; Jules L. Dienstag 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 554 KB

We tested the safety and long-term immunogenicity of two of the early investigative lots of a recombinant-yeast-derived hepatitis B vaccine in immunocompetent adults. Three 10-micrograms doses of recombinant hepatitis B vaccine (Merck Sharp & Dohme Research Laboratories, West Point, PA) were adminis